Evidence map›Paper›PMID 42277012›Full record

ArticleNature communications2026

Author Correction: The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.

Ali Khateb, Anagha Deshpande, Yongmei Feng, Darren Finlay, Joo Sang Lee, Ikrame Lazar, Bertrand Fabre, Yan Li, Yu Fujita, Tongwu Zhang and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Ali KhatebTechnion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Anagha DeshpandeCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Yongmei FengCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Darren FinlayCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8718-9453
Joo Sang LeeCancer Data Science Lab (CDSL), National Cancer Institute, National Institute of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-8564-0848
Ikrame LazarTechnion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Bertrand FabreTechnion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Yan LiCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Yu FujitaCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8916-7303
Tongwu ZhangLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2124-2706
Jun YinCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Ian PassCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Ido LivnehTechnion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Irmela JeremiasResearch Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich, German Center for Environmental Health, Munich, Germany.ORCID http://orcid.org/0000-0003-1773-7677
Carol BurianScripps MD Anderson Cancer Center, La Jolla, CA, USA.
James R MasonScripps MD Anderson Cancer Center, La Jolla, CA, USA.
Ronit AlmogRambam Health Care Campus, Epidemiology Department and Biobank, Haifa, Israel.
Nurit HoreshRambam Health Care Campus, Hematology and Bone marrow Transplantation Department, Haifa, Israel.
Yishai OfranTechnion Integrated Cancer Center, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Kevin BrownLaboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-8558-6711
Kristiina VuoriCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5657-0681
Michael JacksonCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Eytan RuppinCancer Data Science Lab (CDSL), National Cancer Institute, National Institute of Health, Bethesda, MD, USA.
Aniruddha J DeshpandeCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5240-9356
Ze'ev A RonaiCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. ronai@sbpdiscovery.org.ORCID http://orcid.org/0000-0002-3859-0400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42277012
PMCPMC13260805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.